TABLE 3.
Validation of acceptance criteria (2013)
| Test | No. |
% (no./total no.) |
Cost savings ($) | ||||
|---|---|---|---|---|---|---|---|
| Total | Negative | Positive | Indeterminate | Negative tests cancelled | Positive tests accepted | ||
| HSV-1/2 | 974 | 965 | 9 | 0 | 54 (51/95) | 78 (7/9)a | 33,518 |
| VZV | 485 | 480 | 5 | 0 | 57 (27/47) | 100 (5/5) | 17,841 |
| CMV | 429 | 427 | 2 | 0 | 35 (15/43) | 100 (2/2) | 9,637 |
| EV | 238 | 236 | 1 | 1 | 56 (18/32) | 100 (1/1) | 8,589 |
| Total | 2,126 | 2,108 | 17 | 1 | 51 (111/217) | 88 (15/17)a | 69,585 |
a
In each case, both excluded tests were clinically insignificant, according to an infectious disease consultation.